tiprankstipranks
Trending News
More News >
Denali Therapeutics (DE:4DN)
FRANKFURT:4DN

Denali Therapeutics (4DN) Revenue

Compare
7 Followers

Denali Therapeutics Revenue

Denali Therapeutics had a revenue of 0.00 in the quarter ending Dec 31, 2024, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased 100.00%. In the fiscal year ending Dec 31, 2024, Denali Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
443
Market Cap
$1.71B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
0.00-330.53M-100.00%
Dec 31, 2023
330.53M222.07M+204.74%
Dec 31, 2022
108.46M59.80M+122.90%
Dec 31, 2021
48.66M-287.00M-85.50%
Dec 31, 2020
335.66M308.98M+1,158.19%
Dec 31, 2019
26.68M-102.48M-79.34%
Dec 31, 2018
129.16M+∞%
Dec 31, 2017
0.00
Dec 31, 2016
0.00
Dec 31, 2015
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis